Metabolic syndrome and erectile dysfunction: a systematic review and meta-analysis study.

Area of Science:

• Andrology
• Cardiovascular Health
• Metabolic Disorders

Background:

• Metabolic syndrome (MetS) is a cluster of conditions increasing cardiovascular risk.
• The independent clinical significance of MetS versus its individual components in erectile dysfunction (ED) remains debated.
• Existing research presents conflicting evidence regarding the direct link between MetS and ED prevalence.

Purpose of the Study:

• To critically analyze the association between MetS and ED.
• To evaluate the distinct and combined roles of MetS components in the development of ED.
• To clarify the clinical utility of MetS as a diagnostic category for ED.

Main Methods:

• Systematic review and meta-analysis of observational studies (prospective and retrospective).
• Reanalysis of preclinical data from an established animal model of MetS.
• Inclusion of clinical data from over 2697 men with a mean age of 52.7 years.

Main Results:

• MetS demonstrated up to a fourfold increased risk of ED.
• Meta-regression revealed strong associations between MetS components and ED risk.
• Adjusted analyses indicated that comorbidities, rather than MetS itself, were primary drivers of ED.
• Low testosterone's contribution to MetS-associated ED was found to be marginal.

Conclusions:

• Metabolic syndrome (MetS) may be an impractical diagnostic category for studying erectile dysfunction (ED).
• Focusing on and treating individual MetS components is essential for effective ED management.
• The individual components of MetS play a pivotal role in the pathophysiology of ED.